NIKI stock Statistics — Niki BioSolutions, Inc. filings, insiders & smart money

Price chart (1D to 10Y)

Licensed market data — shown to members, not published to the open web.

Beta: Sign in
Shares outstanding: —
Shares float: Sign in
Float %: Sign in
Insider ownership: —
Institutional ownership: Sign in
Short interest: —
Short ratioDays to cover, as published by FINRA: 1.00
Short volume (5D)Share of FINRA reporting-facility volume sold short, daily flow: 27.30%
Short volume (20D)Share of FINRA reporting-facility volume sold short, daily flow: 29.00%
Avg volume (10D): Sign in
Avg volume (3 months)

Source: SEC filings. Information and analytics, not investment advice.

Gross marginFY Dec 23: 2.45%
Operating margin: —
Net margin: —
EBITDA margin: —
Return on equityNet income (FY Dec 25) ÷ average shareholders equity: -6.16%
Return on assetsNet income (FY Dec 25) ÷ average total assets: -7.83%

Cash & equivalentsas of Dec 25: $3.45M
Total cash: Sign in
Total debtBorrowings + finance and operating lease liabilities, as of Dec 22: $129.84K
Debt / equityas of Dec 22: 0.83%
Current ratioas of Dec 25: 0.78
Quick ratio: —
Operating cash flowFY Dec 25: -$1.83M
Free cash flowUnadjusted FCF = CFO − capex · FY Dec 23: -$7.72M
TTM revenue / diluted share: —